Solifenacin succinate salt (CAS 242478-38-2)

Solifenacin succinate salt is a quaternary ammonium compound that acts as a selective antagonist for the muscarinic acetylcholine receptor subtype M3. This chemical is the succinate salt form of solifenacin, which enhances its solubility and stability in aqueous environments, making it more suitable for various research applications. In experimental settings, solifenacin succinate is used to study the mechanisms of cholinergic signaling, particularly focusing on its role in smooth muscle contraction. The M3 receptors are predominantly found in smooth muscles of the gastrointestinal tract and bladder, where they mediate contraction in response to acetylcholine. By blocking these receptors, solifenacin succinate can inhibit the signaling pathways that lead to muscle contraction, providing a useful tool for investigating the molecular underpinnings of muscarinic receptor function. Researchers often utilize solifenacin succinate in studies exploring receptor-ligand interactions, signal transduction pathways, and the regulation of smooth muscle activity. Additionally, this compound is valuable in dissecting the role of M3 receptors in various physiological processes, helping to elucidate the contributions of specific receptor subtypes to overall cholinergic function. The succinate salt form is particularly favored in research due to its improved handling and formulation properties, facilitating detailed experimental analysis.